Neurona Therapeutics clinical trials
Acquired by UCB S.A., Jun 2, 2026 · source ↗
The registry lists 2 studies whose lead sponsor is Neurona Therapeutics. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 9, 2026.
Before and after it joined UCB S.A.
- First submitted before Neurona Therapeutics became part of UCB S.A.
- 2
- First submitted after Neurona Therapeutics became part of UCB S.A.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Neurona Therapeutics2 studies
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All UCB S.A. studies →
- Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))RecruitingNCT05135091Phase 3
Sponsor listed in the registry: Neurona Therapeutics · First submitted before Neurona Therapeutics became part of UCB S.A.
- A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)RecruitingNCT06422923Phase 1/2
Sponsor listed in the registry: Neurona Therapeutics · First submitted before Neurona Therapeutics became part of UCB S.A.